These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17327940)
1. Usefulness of rectally administering [1-(13)C]-butyrate for breath test in patients with active and quiescent ulcerative colitis. Kato K; Ishii Y; Mizuno S; Sugitani M; Asai S; Kohno T; Takahashi K; Komuro S; Iwamoto M; Miyamoto S; Takayama T; Arakawa Y Scand J Gastroenterol; 2007 Feb; 42(2):207-14. PubMed ID: 17327940 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway. De Preter V; Geboes KP; Bulteel V; Vandermeulen G; Suenaert P; Rutgeerts P; Verbeke K Aliment Pharmacol Ther; 2011 Sep; 34(5):526-32. PubMed ID: 21707682 [TBL] [Abstract][Full Text] [Related]
3. Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation. Sedghi S; Keshavarzian A; Klamut M; Eiznhamer D; Zarling EJ Am J Gastroenterol; 1994 Dec; 89(12):2217-21. PubMed ID: 7977245 [TBL] [Abstract][Full Text] [Related]
4. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Simpson EJ; Chapman MA; Dawson J; Berry D; Macdonald IA; Cole A Gut; 2000 Jan; 46(1):73-7. PubMed ID: 10601058 [TBL] [Abstract][Full Text] [Related]
5. Changes in pulmonary function in patients with ulcerative colitis. Mohamed-Hussein AA; Mohamed NA; Ibrahim ME Respir Med; 2007 May; 101(5):977-82. PubMed ID: 17049827 [TBL] [Abstract][Full Text] [Related]
6. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134 [TBL] [Abstract][Full Text] [Related]
7. The (13)C-butyrate breath test: a new non-invasive method for assessing colitis in a murine model. Endo M; Oikawa T; Hoshino T; Hatori T; Matsumoto T; Hanawa T J Pharmacol Sci; 2013; 123(2):176-84. PubMed ID: 24096835 [TBL] [Abstract][Full Text] [Related]
8. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909 [TBL] [Abstract][Full Text] [Related]
9. [The influence of Candida albicans on the course of ulcerative colitis]. Zwolińska-Wcisło M; Budak A; Trojanowska D; Mach T; Rudnicka-Sosin L; Galicka-Latała D; Nowak P; Cibor D Przegl Lek; 2006; 63(7):533-8. PubMed ID: 17203803 [TBL] [Abstract][Full Text] [Related]
10. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. Rezaie A; Khalaj S; Shabihkhani M; Nikfar S; Zamani MJ; Mohammadirad A; Daryani NE; Abdollahi M Ann N Y Acad Sci; 2007 Jan; 1095():305-14. PubMed ID: 17404043 [TBL] [Abstract][Full Text] [Related]
11. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis]. Xiang JY; Ouyang Q; Li GD Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2262-4. PubMed ID: 18001547 [TBL] [Abstract][Full Text] [Related]
12. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615 [TBL] [Abstract][Full Text] [Related]
13. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Den Hond E; Hiele M; Evenepoel P; Peeters M; Ghoos Y; Rutgeerts P Gastroenterology; 1998 Sep; 115(3):584-90. PubMed ID: 9721155 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108 [TBL] [Abstract][Full Text] [Related]
15. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010 [TBL] [Abstract][Full Text] [Related]
17. Hemostatic imbalance in active and quiescent ulcerative colitis. van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695 [TBL] [Abstract][Full Text] [Related]
18. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Turner D; Otley AR; Mack D; Hyams J; de Bruijne J; Uusoue K; Walters TD; Zachos M; Mamula P; Beaton DE; Steinhart AH; Griffiths AM Gastroenterology; 2007 Aug; 133(2):423-32. PubMed ID: 17681163 [TBL] [Abstract][Full Text] [Related]
19. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients. Lok KH; Ng CH; Hung HG; Li KF; Li KK; Szeto ML J Dig Dis; 2008 Nov; 9(4):219-24. PubMed ID: 18959594 [TBL] [Abstract][Full Text] [Related]
20. Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa. De Preter V; Bulteel V; Suenaert P; Geboes KP; De Hertogh G; Luypaerts A; Geboes K; Verbeke K; Rutgeerts P Inflamm Bowel Dis; 2009 Mar; 15(3):335-40. PubMed ID: 18942762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]